Literature DB >> 20408742

Molecularly imprinted therapeutic contact lenses.

Charles J White1, Mark E Byrne.   

Abstract

IMPORTANCE OF THE FIELD: There exists a considerable unmet need for more efficacious delivery of ocular therapeutics. Contact lenses have been developed with high loading and controllable sustained release to overcome limited patient compliance and significant ocular transport limitations. This can best be achieved by extending and controlling the residence time of drugs on the eye surface and thereby limiting drug loss by lacrimation, drainage and non-productive absorption. AREAS COVERED IN THE REVIEW: Within hydrogels, molecular imprinting can be used to create memory for template molecules embedded within a flexible macromolecular network. Control in therapeutic loading and delay of release have been demonstrated with careful attention to the functional monomer/template ratio, the diversity of functional monomers, and the polymer backbone and network structure. Experimental work has also confirmed that macromolecular memory and not structural differences or phenomena are responsible for delayed drug release kinetics compared with non-imprinted systems. A therapeutically relevant amount of drug can be loaded for release to occur over multiple days, which allows the technique to be applied to daily-wear and extended-wear contact lenses. WHAT THE READER WILL GAIN: The focus of this article is to review the emerging field of molecularly imprinted contact lenses and highlight significant accomplishments, trends, as well as future strategies and directions. TAKE HOME MESSAGE: In the past 8 years, molecular imprinting has been used to produce therapeutic contact lenses with enhanced loading and delayed release. Progress in the field has mostly included low-molecular-weight therapeutics such as anti-glaucoma, antihistamine, antibiotic and anti-inflammatory therapeutics used to treat anterior eye disorders. Recently, high molecular weight comfort molecules have also been successfully demonstrated. Current methods can produce lenses of suitable thickness, water content, and mechanical and optical properties compared with commercial lenses on the market today.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20408742     DOI: 10.1517/17425241003770098

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  14 in total

1.  Development of ciprofloxacin-loaded contact lenses using fluorous chemistry.

Authors:  Guoting Qin; Zhiling Zhu; Siheng Li; Alison M McDermott; Chengzhi Cai
Journal:  Biomaterials       Date:  2017-01-31       Impact factor: 12.479

2.  Synthesis and Characterization of Poly(2-hydroxyethylmethacrylate) Contact Lenses Containing Chitosan Nanoparticles as an Ocular Delivery System for Dexamethasone Sodium Phosphate.

Authors:  Gautam Behl; Javed Iqbal; Niall J O'Reilly; Peter McLoughlin; Laurence Fitzhenry
Journal:  Pharm Res       Date:  2016-03-10       Impact factor: 4.200

3.  Ocular drug delivery systems: An overview.

Authors:  Ashaben Patel; Kishore Cholkar; Vibhuti Agrahari; Ashim K Mitra
Journal:  World J Pharmacol       Date:  2013

Review 4.  Innate immunity activation on biomaterial surfaces: a mechanistic model and coping strategies.

Authors:  Kristina N Ekdahl; John D Lambris; Hans Elwing; Daniel Ricklin; Per H Nilsson; Yuji Teramura; Ian A Nicholls; Bo Nilsson
Journal:  Adv Drug Deliv Rev       Date:  2011-07-08       Impact factor: 15.470

Review 5.  Novel drug delivery systems for glaucoma.

Authors:  E Lavik; M H Kuehn; Y H Kwon
Journal:  Eye (Lond)       Date:  2011-04-08       Impact factor: 3.775

6.  Controlled Release of Multiple Therapeutics from Silicone Hydrogel Contact Lenses.

Authors:  Charles James White; Stephen Anthony DiPasquale; Mark Edward Byrne
Journal:  Optom Vis Sci       Date:  2016-04       Impact factor: 1.973

7.  Update and optimal use of a brinzolamide-timolol fixed combination in open-angle glaucoma and ocular hypertension.

Authors:  Misha F Syed; Emma Kr Loucks
Journal:  Clin Ophthalmol       Date:  2011-09-08

8.  Combination therapies in ophthalmology: implications for intravitreal delivery.

Authors:  Gholam A Peyman; Kamran Hosseini
Journal:  J Ophthalmic Vis Res       Date:  2011-01

9.  Bimatoprost Imprinted Silicone Contact Lens to Treat Glaucoma.

Authors:  Feng Yan; Yanxia Liu; Shulan Han; Qingsong Zhao; Nannan Liu
Journal:  AAPS PharmSciTech       Date:  2020-01-13       Impact factor: 4.026

Review 10.  Nanotechnology approaches for ocular drug delivery.

Authors:  Qingguo Xu; Siva P Kambhampati; Rangaramanujam M Kannan
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.